'It's not my greengrocer, it's someone from the medical profession': A qualitative study regarding acceptability of deceptive and open-label placebo prescribing in France.
ethics
open-label
patients' attitude
placebo
placebo attitudes
Journal
British journal of health psychology
ISSN: 2044-8287
Titre abrégé: Br J Health Psychol
Pays: England
ID NLM: 9605409
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
revised:
09
07
2022
received:
07
01
2022
accepted:
11
08
2022
medline:
11
4
2023
pubmed:
11
9
2022
entrez:
10
9
2022
Statut:
ppublish
Résumé
To explore participants' views regarding clinical use of deceptive placebo (DP) and open-label placebo (OLP) treatments. Qualitative thematic analysis. We conducted eight semi-structured interviews with healthy participants in an experimental trial comparing the efficacy of OLP and DP (Clinical trials n°NCT03934138). Interviewees' opinions were solicited following administration of placebos during the trial. Interviews were analysed using data-driven analysis. We identified three themes. First, participants considered trust central in judging a placebo treatment to be acceptable. They expressed the importance of an implicit trust both in their health care professionals' (HCPs') competency as well as in the profession at large. A second theme was the perception of how placebo treatments might solve health problems. Acceptability of both types of placebo treatments was dependent on the perception patients had about the treatment solving their problem and/or doubts regarding the effectiveness of placebos The third theme encompassed perceived risks associated with placebo prescribing. Some comments viewed placebos positively as facilitating reduced medication intake. However, participants also identified the potential of placebos to generate adverse side effects. Treatment acceptability by patients is a pre-requisite, alongside effectiveness, to harness OLPs in clinical care. Our study identified the importance of trust in HCPs prescribing placebos, the clinical effectiveness of placebos and the potential risks of these interventions in assessing their acceptability. Future research is needed to explore the contexts in which placebos might be used, and how best to communicate information about placebo interventions.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
273-290Informations de copyright
© 2022 The Authors. British Journal of Health Psychology published by John Wiley & Sons Ltd on behalf of British Psychological Society.
Références
Annoni, M. (2018). The ethics of placebo effects in clinical practice and research. International Review of Neurobiology, 139, 463-484.
Annoni, M., & Miller, F. G. (2014). Placebos in clinical practice: An ethical overview. Douleur et Analgésie, 27, 215-220.
Bardin, L. (2013). L'analyse de contenu. Presses Universitaires de France.
Benedetti, F. (2020). Placebo effects. Wiley.
Benedetti, F., Carlino, E., & Pollo, A. (2011). Hidden administration of drugs. Clinical Pharmacology and Therapeutics, 90, 651-661.
Bernstein, M. H., Locher, C., Kube, T., Buergler, S., Stewart-Ferrer, S., & Blease, C. (2020). Putting the 'Art' into the 'Art of Medicine': The under-explored role of artifacts in placebo studies. Frontiers in Psychology, 11, 1354.
Bernstein, M. H., Locher, C., Stewart-Ferrer, S., Buergler, S., DesRoches, C. M., Dossett, M. L., Miller, F. G., Grose, D., & Blease, C. R. (2020). Primary care providers' use of and attitudes towards placebos: An exploratory focus group study with US physicians. British Journal of Health Psychology, 25, 596-614.
Bhugra, D., & Ventriglio, A. (2015). Do cultures influence placebo response? Acta Psychiatrica Scandinavica, 132, 227-230.
Bishop, F. L., Aizlewood, L., & Adams, A. E. M. (2014). When and why placebo-prescribing is acceptable and unacceptable: A focus group study of patients' views. PLoS One, 9, e101822.
Bishop, F. L., Jacobson, E. E., Shaw, J., & Kaptchuk, T. J. (2012). Participants' experiences of being debriefed to placebo allocation in a clinical trial. Qualitative Health Research, 22, 1138-1149.
Blease, C. (2018). consensus in placebo studies: Lessons from the philosophy of science. Perspectives in Biology and Medicine, 61, 412-429.
Blease, C., & Annoni, M. (2019). Overcoming disagreement: A roadmap for placebo studies. Biology and Philosophy, 34, 1-26.
Blease, C., Colloca, L., & Kaptchuk, T. J. (2016). Are open-label placebos ethical? Informed consent and ethical equivocations. Bioethics, 30, 407-414.
Blease, C. R. (2019). The role of placebos in family medicine: 'Implications of evidence and ethics for general practitioners'. Australian journal of general practice, 48, 700-705.
Blease, C. R., Bernstein, M. H., & Locher, C. (2019). Open-label placebo clinical trials: Is it the rationale, the interaction or the pill? BMJ Evidence-based Medicine, 25, 159-165.
Bliamptis, J., & Barnhill, A. (2021). Physician perspectives on placebo ethics. Journal of Medical Ethics. https://doi.org/10.1136/medethics-2021-107446
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3, 77-101.
Braun, V., & Clarke, V. (2013). Successful qualitative research: A practical guide for beginners. SAGE.
Braun, V., & Clarke, V. (2019). To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales. Qualitative Research in Sport, Exercise and Health, 13, 201-216.
Carvalho, C., Caetano, J. M., Cunha, L., Rebouta, P., Kaptchuk, T. J., & Kirsch, I. (2016). Open-label placebo treatment in chronic low back pain: A randomized controlled trial. Pain, 157, 2766-2772.
Charlesworth, J. E. G., Petkovic, G., Kelley, J. M., Hunter, M., Onakpoya, I., Roberts, N., Miller, F. G., & Howick, J. (2017). Effects of placebos without deception compared with no treatment: A systematic review and meta-analysis. Journal of Evidence-Based Medicine, 10, 97-107.
Coolican, H. (2017). Research methods and statistics in psychology. Routledge.
Di Blasi, Z., Harkness, E., Ernst, E., Georgiou, A., & Kleijnen, J. (2001). Influence of context effects on health outcomes: A systematic review. Lancet, 357, 757-762.
Druart, L., Graham Longsworth, S., Rolland, C., Dolgopoloff, M., Terrisse, H., Bosson, J.-L., & Pinsault, N. (2020). Can an open-label placebo be as effective as a deceptive placebo? Methodological considerations of a study protocol. Medicines (Basel), 7, 3.
Ernst, E., & Resch, K. L. (1995). Concept of true and perceived placebo effects. BMJ, 311, 551-553.
Fässler, M., Gnädinger, M., Rosemann, T., & Biller-Andorno, N. (2011). Placebo interventions in practice: A questionnaire survey on the attitudes of patients and physicians. The British Journal of General Practice, 61, 101-107.
Fässler, M., Meissner, K., Schneider, A., & Linde, K. (2010). Frequency and circumstances of placebo use in clinical practice - a systematic review of empirical studies. BMC Medicine, 8, 15.
Foddy, B. (2009). A duty to deceive: placebos in clinical practice. The American Journal of Bioethics, 9, 4-12.
Friesen, P., & Blease, C. (2018). Placebo effects and racial and ethnic health disparities: An unjust and underexplored connection. Journal of Medical Ethics, 44, 774-781.
Grünbaum, A. (1986). The placebo concept in medicine and psychiatry. Psychological Medicine, 16, 19-38.
Haas, J. W., Rief, W., & Doering, B. K. (2021). Open-label placebo treatment: Outcome expectations and general acceptance in the lay population. International Journal of Behavioral Medicine, 28, 444-454. https://doi.org/10.1007/s12529-020-09933-1
Hammami, M. M., Hammami, S., Aboushaar, R., & Aljomah, A. S. (2019). Lay people's ethical attitudes to placebo treatment: A Q-Methodology Study. Patient Preference and Adherence, 13, 1599-1617.
Hardman, D. I., Geraghty, A. W., Howick, J., Roberts, N., & Bishop, F. L. (2019). A discursive exploration of public perspectives on placebos and their effects. Health Psychology Open, 6, 2055102919832313.
Hardman, D. I., Geraghty, A. W., Lewith, G., Lown, M., Viecelli, C., & Bishop, F. L. (2020). From substance to process: A meta-ethnographic review of how healthcare professionals and patients understand placebos and their effects in primary care. Health (London, England), 24, 315-340.
Heiss, U., Rosenfield, M., & Bernstein, M. (2021). Can the Open-Label Placebo rationale be optimized? Frontiers in Pain Research, 2, 734882. https://doi.org/10.3389/fpain.2021.734882
Howe, L. C., Hardebeck, E. J., Eberhardt, J. L., Markus, H. R., & Crum, A. J. (2022). White patients' physical responses to healthcare treatments are influenced by provider race and gender. Proceedings of the National Academy of Sciences of the United States of America, 119, e2007717119.
Howe, L. C., Leibowitz, K. A., & Crum, A. J. (2019). When your doctor "Gets It" and "Gets You": The critical role of competence and warmth in the patient-provider interaction. Frontiers in Psychiatry, 10, 475.
Howick, J. (2017). The relativity of ‘placebos’: Defending a modified version of Grünbaum's definition. Synthese, 194, 1363-1396.
Kaptchuk, T. J., & Miller, F. G. (2015). Placebo effects in medicine. The New England Journal of Medicine, 373, 8-9.
Kelley, J. M., Kraft-Todd, G., Schapira, L., Kossowsky, J., & Riess, H. (2014). The influence of the patient-clinician relationship on healthcare outcomes: A systematic review and meta-analysis of randomized controlled trials. PLoS One, 9, e94207.
Köteles, F., & Ferentzi, E. (2012). Ethical aspects of clinical placebo use: What do laypeople think? Evaluation and the Health Professions, 35, 462-476.
Linde, K., Atmann, O., Meissner, K., Schneider, A., Meister, R., Kriston, L., & Werner, C. (2018). How often do general practitioners use placebos and non-specific interventions? Systematic review and meta-analysis of surveys. PLoS One, 13, e0202211.
Locher, C., Buergler, S., Frey Nascimento, A., Kost, L., Blease, C., & Gaab, J. (2021). Lay perspectives of the open-label placebo rationale: A qualitative study of participants in an experimental trial. BMJ Open, 11, e053346.
Locher, C., Frey Nascimento, A., Kirsch, I., Kossowsky, J., Meyer, A., & Gaab, J. (2017). Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia. Pain, 158, 2320-2328.
Locher, C., Gaab, J., Blease, C., Inderbinen, M., Kost, L., & Koechlin, H. (2019). Placebos are part of the solution, not the problem. An exemplification of the case of antidepressants in pediatric chronic pain conditions. Frontiers in Psychiatry, 10, 998.
Marsili, N. (2014). Lying as a scalar phenomenon. In Certainty-uncertainty-and the attitudinal space in between (pp. 153-173). John Benjamins Publishing Company.
Miller, F. G. (2018). Reining in the placebo effect. Perspectives in Biology and Medicine, 61, 335-348.
Moerman, D. E., & Jonas, W. B. (2002). Deconstructing the placebo effect and finding the meaning response. Annals of Internal Medicine, 136, 471-476.
Ortiz, R., Chandros Hull, S., & Colloca, L. (2016). Patient attitudes about the clinical use of placebo: Qualitative perspectives from a telephone survey. BMJ Open, 6, e011012.
Pugh, J., Kahane, G., Maslen, H., & Savulescu, J. (2016). Lay attitudes toward deception in medicine: Theoretical considerations and empirical evidence. AJOB Empirical Bioethics, 7, 31-38.
Sekhon, M., Cartwright, M., & Francis, J. J. (2017). Acceptability of healthcare interventions: An overview of reviews and development of a theoretical framework. BMC Health Services Research, 17, 88.
Specker Sullivan, L. (2021). More than consent for ethical open-label placebo research. Journal of Medical Ethics, 47(12), e7.
Street, R. L., Jr., Makoul, G., Arora, N. K., & Epstein, R. M. (2009). How does communication heal? Pathways linking clinician-patient communication to health outcomes. Patient Education and Counseling, 74, 295-301.
Turner, A. (2011). ‘Placebos’ and the logic of placebo comparison. Biology and Philosophy, 27, 419-432.
Ventriglio, A., Magnifico, G., Borraccino, L., Rinaldi, A., & Bellomo, A. (2018). Placebo and cultural responses. Nordic Journal of Psychiatry, 72, S33-S35.
von Wernsdorff, M., Loef, M., Tuschen-Caffier, B., & Schmidt, S. (2021). Effects of open-label placebos in clinical trials: A systematic review and meta-analysis. Scientific Reports, 11, 3855.